Questions Raised About Invokana Label Expansion For Cv Risk Reduction | Latest News RSS feed
Questions Raised About Invokana Label Expansion For Cv Risk Reduction - Latest News
Amarin Slides as Bulls Battle Bears After Fish-Oil Results
Full results for Amarin Corp.’s Vascepa fish-oil pill for high-risk cardiovascular patients ... patients with high risk prior to label expansion in 2019 or early 2020. “Sub-analyses partially alleviat... read more
Amarin's Mineral Menace
The FDA briefing documents raised questions about ... Amarin had to show a reduction in major cardiovascular events in the REDUCE-IT study prior to gaining the label expansion. read more
EMDAC Wants Cardiovascular Outcomes for Vascepa
When it came to the main point of discussion, and the potential efficacy of Vascepa at reducing cardiovascular risk, there were many questions raised. Committee member ... vote in the 10/16 Panel on V... read more
Looking for another news?
Johnson & Johnson CEO Discusses Q4 2013 Results - Earnings Call Transcript
Additional country rollouts and expansion of the label ... Cardiovascular and Renal Drugs Advisory Committee voted against the approval of the use of XARELTO in patients with acute coronary syndrome. ... read more
Who Started this Ruckus, Anyway?
And because their ire has been raised, then the main stream scientists feel justified in ignoring them. I originally viewed this as a chicken and egg problem, but after delving into this considerably, ... read more
Journal of the American Academy of Orthopaedic Surgeons:
Typically, these are devices that support or sustain human life, are of substantial importance in preventing impairment of human health, present a potentially unreasonable risk of illness ... discussi... read more
Amarin Corporation PLC (AMRN) CEO John Thero Presents Primary REDUCE-IT Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association ...
And so, I’d say that certainly the seesaw has swung in the direction of acknowledging that triglycerides are a possible risk factor for cardiovascular ... Like INVOKANA just got the label ... read more
Prol-position news 7
Issue 7 of prol-position's news sheet about workers' struggles across the world. Contains articls on the anti-CPE struggle, student movement in Greece, welfare in Germany, call centres in Delhi and mo... read more